👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

PriceSmart director Jeffrey Fisher sells shares worth $497,555

Published 2024-11-08, 07:02 p/m
PSMT
-

Jeffrey Fisher, a director at PriceSmart Inc. (NASDAQ:PSMT), has recently sold 5,478 shares of the company, generating approximately $497,555. The shares were sold at an average price of $90.828, with individual transaction prices ranging from $90.680 to $91.000 per share. Following this transaction, Fisher holds 21,646 shares indirectly through the Fisher Family Trust and 1,965 shares directly.

InvestingPro Insights

As Jeffrey Fisher reduces his stake in PriceSmart Inc. (NASDAQ:PSMT), investors might find it valuable to consider some key financial metrics and insights provided by InvestingPro.

PriceSmart's current market capitalization stands at $2.69 billion, with a price-to-earnings (P/E) ratio of 19.76. This P/E ratio is particularly interesting when viewed alongside one of the InvestingPro Tips, which suggests that PSMT is "Trading at a low P/E ratio relative to near-term earnings growth." This could indicate potential undervaluation, especially considering the company's revenue growth of 11.38% over the last twelve months.

Another noteworthy InvestingPro Tip highlights that PriceSmart "Has maintained dividend payments for 18 consecutive years." This consistency in dividend payments, coupled with a current dividend yield of 1.29%, may appeal to income-focused investors. The company has also demonstrated strong dividend growth, with a 26.09% increase in the last twelve months.

It's worth noting that PriceSmart's stock has shown impressive performance, with a one-year price total return of 41.21%. This significant return might provide context for Director Fisher's decision to sell a portion of his holdings, potentially as part of a portfolio rebalancing strategy.

For investors seeking a more comprehensive analysis, InvestingPro offers 9 additional tips for PriceSmart, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.